Symbiotics is the leading market access platform for impact investing, dedicated to financing micro- small and medium enterprises and low- and middle-income households in emerging and frontier markets.

Symbiotics has structured and originated deals for more than USD 6.5 billion. These investments have been purchased by fund mandates and specialized fund managers.

Roland Dominicé

CEO – Symbiotics

David Grimaud

Head of Asset Management – Symbiotics

Dirk Dijksma

Head of Innovation Investments – Symbiotics